Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

BTA safely and effectively treats hair loss, and works better with FNS.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Some drugs used to treat immune conditions may cause different types of hair loss.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Blocking a specific receptor slows down hair loss in mice.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Oral pulse steroids reduce TNF-α levels, improving alopecia areata.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Some drugs for inflammation may cause psoriasis-like hair loss.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Early diagnosis and treatment are crucial to prevent permanent hair loss from TNFα inhibitors in scalp psoriasis.

Alpha-blockers are the most effective and widely used treatment for lower urinary tract symptoms, with minimal side effects.

Forsythiaside A reduces kidney damage from sepsis by lowering inflammation and cell death.